 Multiple-dose dose-response relationship topical carbonic anhydrase inhibitor multiple-dose dose-response curve five-center double-masked placebo-controlled parallel study patients bilateral primary open angle glaucoma ocular hypertension intraocular pressure mm Hg washout ocular hypotensive medications Patients doses AM PM days parallel intraocular pressure curves prestudy day curves days significant dose-response relationship minimal-effect dose active hours peak mean percent decrease pressure hours